Thailand’s military-installed government intends to break the patent of a second-line HIV/Aids drug and a cardio-vascular drug, alarming major Western pharmaceutical companies concerned about Bangkok’s growing challenge to their intellectual property rights.

The move marks a sharp intensification of Thailand’s threat to the global drug industry, as the first country with significant production capacity to use World Trade Organisation rules to challenge patents.